DIASTAT ANTINUCLEAR ANTIBODY, ANTIGEN, CONTROL FANA200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-03-06 for DIASTAT ANTINUCLEAR ANTIBODY, ANTIGEN, CONTROL FANA200 manufactured by Euro Diagnostica Ab.

Event Text Entries

[69373268] The customer, (b)(6), stated that multiple samples resulting positive by the ana screen (fana200, lot ts 2076) result negative during the secondary autoantibody specificity testing. The customer stated that both levels of controls resulted within manufacturer range. The customer stated that no ana results were reported out from customer. No device has been returned to euro diagnostica. Testing of retain material at euro diagnostica with a sample panel form healthy donors showed that there was an increased risk for equivocal sample results with the fana200 lot ts 2076. Investigation suggests that the plate coating results in high background, and the igg conjugate is unstable over time. The shelf-life of the product cannot be guaranteed. There is a risk that users get false positive test results. This may not cause a safety risk to patients, but is a product malfunction. However based on product information to customers, there is a risk that treatment may be started up based on a false positive result, which could be critical for patient health and safety. Based on data from complaint investigation, the quality review board decision is that fana200 lot ts2076 is recalled to avoid risk to patient health and safety. The recall decision was made feb. 14. All affected countries regulatory authorities, as well as all affected euro diagnostica customers, have been notified of the recall. Other fana lots in house, not yet released to market, have been quarantined awaiting further investigation. A field safety notice was sent out, and customers were advised to re-test all positive sample results if treatment was initiated based on results from ana ts 2076. The extent of the problem is presently deemed to be only fana200 ts 2076. Investigation is still on-going to determine if other euro diagnostica products are affected. Access to the production emdr account was given until friday evening, march 3. Hence, the mdr could not be filed until now.
Patient Sequence No: 1, Text Type: N, H10


[69373269] The customer, (b)(6), stated that multiple samples resulting positive by the ana screen (fana200, lot ts 2076) result negative during the secondary autoantibody specificity testing. The customer stated that both levels of controls resulted within manufacturer range. The customer stated that no ana results were reported out from customer. Testing of retain material at euro diagnostica with a sample panel form healthy donors showed that there was an increased risk for equivocal sample results with the fana200 lot ts 2076.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9616003-2017-00001
MDR Report Key6379820
Date Received2017-03-06
Date of Report2017-03-06
Date of Event2017-01-30
Date Mfgr Received2017-02-02
Device Manufacturer Date2016-07-20
Date Added to Maude2017-03-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS NINA CARLQVIST
Manufacturer StreetP. O. BOX 50117
Manufacturer CityMALMO, SKANE 20211
Manufacturer CountrySW
Manufacturer Postal20211
Manufacturer Phone640537632
Manufacturer G1EURO DIAGNOSTICA AB
Manufacturer StreetP. O. BOX 50117
Manufacturer CityMALMO, SKANE 20211
Manufacturer CountrySW
Manufacturer Postal Code20211
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameDIASTAT ANTINUCLEAR ANTIBODY, ANTIGEN, CONTROL
Generic NameANA
Product CodeLKJ
Date Received2017-03-06
Catalog NumberFANA200
Lot NumberTS 2076
Device Expiration Date2017-08-21
OperatorBIOMEDICAL ENGINEER
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerEURO DIAGNOSTICA AB
Manufacturer AddressP. O. BOX 50117 MALMO, SKANE 20211 SW 20211


Patients

Patient NumberTreatmentOutcomeDate
10 2017-03-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.